Do you want to read an article? Please log in or register.
Machine Learning for Early Lung Cancer Identification Using Routine Clinical and Laboratory Data
Lung Cancer
COMMENTED
Related content
Lung Cancer
Predicting survival following surgical resection of lung cancer using clinical and pathological variables: The development and validation of the LNC-PATH score
Lung Cancer.
Balata H, Foden P, Edwards T, Chaturvedi A, Elshafi M, Tempowski A, Teng B, Whittemore P, Blyth KG, Kidd A, Ellames D, Flint LA, Robson J, Teh E, Jones R, Batchelor T, Crosbie P, Booton R, Evison M
doi: 10.1016/j.lungcan.
RECOMMENDED
Further Publications
Identification of potentially undiagnosed patients with nontuberculous mycobacterial lung disease using machine learning applied to primary care data in the UK
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Eur Respir J.
Doyle OM, van der Laan R, Obradovic M, McMahon P, Daniels F, Pitcher A, Loebinger MR
doi: 10.1183/13993003.00045-2020.
RECOMMENDED
ARDS
Machine Learning Classifier Models Can Identify ARDS Phenotypes Using Readily Available Clinical Data
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Am J Respir Crit Care Med.
Sinha P, Churpek MM, Calfee CS
doi: 10.1164/rccm.202002-0347OC.
RECOMMENDED
Lung Cancer
Impact of Lung Parenchymal-Only Failure on Overall Survival in Early-Stage Lung Cancer Patients Treated With Stereotactic Ablative Radiotherapy
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Clin Lung Cancer.
Elbanna M, Shiue K, Edwards D, Cerra-Franco A, Agrawal N, Hinton J, Mereniuk T, Huang C, Ryan JL, Smith J, Aaron VD, Burney H, Zang Y, Holmes J, Langer M, Zellars R, Lautenschlaeger T
doi: 10.1016/j.cllc.2020.05.024.
RECOMMENDED
Lung Cancer
Clinical Outcomes and Predictors of Lung Toxicity After Multiple Courses of Lung Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Clin Lung Cancer.
Muller DA, Dutta SW, Aliotta E, Sanders JC, Wijesooriya K, Watkins WT, Larner JM
doi: 10.1016/j.cllc.2020.06.006.
Lung Cancer
Application of clinical trial inclusion criteria to clinical practice patients to quantify the burden of CNS metastases on health-related quality of life and healthcare resource use in patients with NSCLC
Lung Cancer.
Crane G, Smoljanovic V, Khan N, Gally S, Tomasini P, Lara N, Gondos A, Hammerschmidt S
doi: 10.1016/j.lungcan.
RECOMMENDED
Lung Cancer
Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503).
Lancet Respir Med.
Altorki NK, Wang X, Wigle , Gu L, Darling G, Ashrafi AS, Landrenau R, Miller D, Liberman M, Jones DR, Keenan R, Conti M, Wright G, Veit LJ, Ramalingam SS, Kamel M, Pass HI, Mitchell JD, Stinchcombe T, Vokes E, Kohman L
doi: 10.1016/S2213-2600
COMMENTED
Lung Cancer
Incidence of second and higher order smoking-related primary cancers following lung cancer: a population-based cohort study
Thorax.
Barclay ME, Lyratzopoulos G, Walter FM, Jefferies S, Peake MD, Rintoul RC
doi: 10.1136/thoraxjnl-2018-212456.
RECOMMENDED
Lung Cancer
Identification of novel epigenetic abnormalities as sputum biomarkers for lung cancer risk among smokers and COPD patients
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Lung Cancer.
Tessema M, Tassew DD, Yingling CM, Do K, Picchi MA, Wu G, Petersen H, Randell S, Lin Y, Belinsky SA, Tesfaigzi Y
doi: 10.1016/j.lungcan.2020.05.017.